Prospective evaluation on the effects of anamorelin on blood zinc level and changes in grip strength in advanced gastrointestinal cancer patients with cancer cachexia
Not Applicable
- Conditions
- gastric cancer/ colorectal cancer/ pancreatic cancer
- Registration Number
- JPRN-UMIN000045122
- Lead Sponsor
- Sendai City Medical Center Sendai Open hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
a. Patients with contraindications to the administration of anamorelin b. Patients who are judged by the attending physician, or the department or facility to which the attending physician belongs, to be undesirable to participate in the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in blood zinc levels after 3 weeks (Allow 1 week before or after) of anamorelin administration
- Secondary Outcome Measures
Name Time Method Improvement in grip strength and body composition measurements, change from baseline in LBM and body weight at each assessment period, change from baseline in appetite-related item scores according to the patient pamphlet, dose intensity and occurrence of side effects in patients undergoing chemotherapy